These exosomal miRNAs target PLAU, AMOTL1, NRP1, and ETS2 in endothelial cells, disrupting angiogenic signaling
AITD can occur both in isolation and in combination with other autoimmune disorders, such as type 1 diabetes, celiac disease, vitiligo, etc
Studies using rat models with transected Achilles tendons showed BPC-157 treatment resulted in accelerated recovery with increased load to failure, superior Achilles Functional Index scores, enhanced mononuclear cell infiltration, improved collagen fiber organization, and smaller persistent defects compared to untreated controls
Experimental findings indicate that the compound may trigger cellular mechanisms that release fatty acids from fat stores without significantly altering insulin or IGF-1 levels